| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 07/24/2013 | CN102614459B Traditional Chinese medicine spray for rapidly curing myocardial ischemia and preparation method thereof |
| 07/24/2013 | CN102579688B Blood pressure reducing chrysanthemum and dogbane leaf traditional Chinese medicine preparation |
| 07/24/2013 | CN102552125B Injection composition containing oxiracetam and preparation method and application thereof |
| 07/24/2013 | CN102552122B Method for preparing sinomenine hydrochloride injection |
| 07/24/2013 | CN102441134B Chinese herbal medicinal composition, preparation, and preparation method and application thereof |
| 07/24/2013 | CN102430085B Chinese medicine for treating coronary heart disease |
| 07/24/2013 | CN102423457B Traditional Chinese medicine capsules for treating coronary heart disease |
| 07/24/2013 | CN102357195B Medicinal composition for treating cardiovascular and cerebrovascular diseases, and preparation method and application thereof |
| 07/24/2013 | CN102327368B Chinese lizardtail rhizome or herb rootstock total effective fraction and preparation method and application thereof |
| 07/24/2013 | CN102240331B Ointment mainly for treating rheumatoid arthritis |
| 07/24/2013 | CN102228457B Pharmaceutical composition for treating diabetes and complication thereof |
| 07/24/2013 | CN102093341B Indole ring substituted pyrazole carboxylic acid endothelin receptor antagonist as well as preparation method and application thereof |
| 07/24/2013 | CN102058560B Dihydromyricetin soft capsules and preparation method thereof |
| 07/24/2013 | CN101698051B Application of traditional Chinese medicine composite in preparing medicine treating climacteric syndrome |
| 07/24/2013 | CN101668760B Aminopyrimidines useful as inhibitors of protein kinases |
| 07/24/2013 | CN101405264B Piperidinyl urea derivatives as inhibitors of soluble epoxide hydrolase for the treatment of hypertension, inflammations and other diseases |
| 07/23/2013 | US8492560 Quinazoline derivatives as angiogenesis inhibitors |
| 07/23/2013 | US8492416 2-oxo-1-pyrrolidine derivatives, processes for preparing them and their uses |
| 07/23/2013 | US8492389 Inhibitors of human phosphatidylinositol 3-kinase delta |
| 07/23/2013 | US8492376 Heteroaryl-cyclohexyl-tetraazabenzo[e]azulenes |
| 07/23/2013 | US8491931 Treatment of faecal incontinence and other conditions with 1R, 2S-methoxamine |
| 07/23/2013 | US8491906 Selective targeting of tumor vasculature using antibody molecules |
| 07/23/2013 | CA2664004C Glucagon receptor antagonist compounds, compositions containing such compounds and methods of use |
| 07/23/2013 | CA2599348C Indole compound and use thereof |
| 07/23/2013 | CA2428114C Apolipoprotein analogues |
| 07/23/2013 | CA2377357C Fish serine proteinases and their pharmaceutical and cosmetic use |
| 07/23/2013 | CA2357950C Therapeutic phosphodiesterase inhibitors |
| 07/18/2013 | WO2013106702A1 Halofuginol derivatives and their use in cosmetic and pharmaceutical compositions |
| 07/18/2013 | WO2013106358A1 Method of treating hyperlipidemia and atherosclerosis with mir-30c |
| 07/18/2013 | WO2013105066A1 Salts of an ip receptor agonist |
| 07/18/2013 | WO2013105065A1 Fused piperidines as ip receptor agonists for the treatment of pah and related disorders |
| 07/18/2013 | WO2013105063A1 Fused piperidines as ip receptor agonists for the treatment of pulmonary arterial hypertension (pah) and related disorders |
| 07/18/2013 | WO2013105061A1 Fused dihydropyrido [2,3 -b] pyrazines as ip receptor agonists for the treatment of pulmonary arterial hypertension (pah) and related disorders |
| 07/18/2013 | WO2013105058A1 7,8- dihydropyrido [3, 4 - b] pyrazines as ip receptor agonists for the treatment of pulmonary arterial hypertension (pah) and related disorders |
| 07/18/2013 | WO2013105057A1 Fused pyrroles as ip receptor agonists for the treatment of pulmonary arterial hypertension (pah) and related disorders |
| 07/18/2013 | WO2013105047A2 New topical use of zerumbone |
| 07/18/2013 | WO2013104703A1 Substituted annulated pyrimidines and triazines, and use thereof |
| 07/18/2013 | WO2013104598A2 Substituted, annulated imidazoles and pyrazoles, and use thereof |
| 07/18/2013 | WO2013104597A1 Substituted triazine derivatives and use thereof as stimulators of soluble guanylate cyclase |
| 07/18/2013 | WO2013104577A1 Benzimidazolyl-acetamide derivatives useful as potassium channel modulators |
| 07/18/2013 | WO2013104342A1 Crystalline forms of azilsartan medoxomil potassium and preparation and uses thereof |
| 07/18/2013 | WO2013104318A1 Crystal form of prostaglandin analogue, and preparation method and use thereof |
| 07/18/2013 | WO2013070852A3 Compounds and compositions used to epigenetically transform cells and methods related thereto |
| 07/18/2013 | WO2013070116A3 Novel antithrombotic and antiatherosclerotic agent and method for producing same (variants) |
| 07/18/2013 | US20130184519 Cardiac support device with differential compliance |
| 07/18/2013 | US20130184333 Growth factor isoform |
| 07/18/2013 | US20130184325 Treatment of hepatocyte growth factor (hgf) related diseases by inhibition of natural antisense transcript to hgf |
| 07/18/2013 | US20130184281 Use of pteridine derivatives for the treatment of increased intracranial pressure, secondary ischemia, and disorders associated with an increased level of cytotoxic reactive oxygen species |
| 07/18/2013 | US20130184242 Pharmaceutical Composition for Topical Application |
| 07/18/2013 | US20130181107 Furnace mount and method of installation |
| 07/18/2013 | CA2860855A1 Substituted annulated pyrimidines and triazines, and use thereof |
| 07/18/2013 | CA2860847A1 Substituted, annulated imidazoles and pyrazoles, and use thereof |
| 07/18/2013 | CA2860842A1 Methods of treating or preventing insulin resistance and associated diseases and conditions |
| 07/18/2013 | CA2860826A1 Substituted triazine derivatives and use thereof as stimulators of soluble guanylate cyclase |
| 07/17/2013 | EP2615100A1 Fructosylated puerarin, and preparation method therefor and use thereof |
| 07/17/2013 | EP2615094A2 Sesterterpene compounds and use thereof |
| 07/17/2013 | EP2614823A1 Use of triazolylpiperidine derivatives |
| 07/17/2013 | EP2614822A2 Atorvastatin Derivatives |
| 07/17/2013 | EP2614061A1 Quinoline and quinoxaline derivatives as kinase inhibitors |
| 07/17/2013 | EP2613795A2 Treatment of diseases |
| 07/17/2013 | EP2613767A2 Compositions comprising a fatty acid oil mixture, a free fatty acid, and a statin |
| 07/17/2013 | EP2613766A2 Compositions comprising a fatty acid oil mixture comprising epa and dha in free acid form, a surfactant, and a statin |
| 07/17/2013 | CN103210085A Compositions for use in treating or diagnosing bone disorders and/or cardiovascular disorders |
| 07/17/2013 | CN103209997A High purity heparin and production method therefor |
| 07/17/2013 | CN103209981A Hetero ring-fused imidazole derivative having ampk activating effect |
| 07/17/2013 | CN103209968A Pluripotent stem cell cardiomyocyte differentiation-promoting agent |
| 07/17/2013 | CN103205410A Recombinant microplasmin, its preparation method and application |
| 07/17/2013 | CN103205407A Extended soluble ph20 polypeptides and uses thereof |
| 07/17/2013 | CN103205337A Glutinous rice wine prepared with sunflower discs and gynostemma pentaphyllum and preparation method thereof |
| 07/17/2013 | CN103204921A Secretory protein with chemotactic activity, and coding sequence and application thereof |
| 07/17/2013 | CN103204909A Antihypertensive active peptide VPPIPP (valine-proline-proline-isoleucine-proline-proline) |
| 07/17/2013 | CN103204907A Raja porosa cartilage polypeptide angiogenesis inhibitory factor, and preparation method and application thereof |
| 07/17/2013 | CN103204862A 6-phenylimidazol[2, 1-b]thiazole-3-amide derivative, its preparation method and application |
| 07/17/2013 | CN103204852A Heteroaryl amide analogues as P2X7 antagonists |
| 07/17/2013 | CN103204850A Acetylsalicylic acid berberine salt, preparation method and application thereof |
| 07/17/2013 | CN103204827A Benzothiadiazole compounds as protein kinase inhibitors, and preparation method and application thereof |
| 07/17/2013 | CN103204825A Benzothiazole compounds as protein kinase inhibitors, and preparation method and application thereof |
| 07/17/2013 | CN103204822A Benzoxazole compounds as protein kinase inhibitors, and preparation method and application thereof |
| 07/17/2013 | CN103204815A 4-(4-cyano-2-thioaryl)dihydropyrimidinones And Use Thereof |
| 07/17/2013 | CN103204813A Condensed imidazole derivatives as TRPV3 antagonist |
| 07/17/2013 | CN103203020A Application of statin medicines in preparing medicines used for treating chronic subdural hematoma |
| 07/17/2013 | CN103203019A Multiple-variable Dose Regimen For Treating Tnfalpha-related Disorders |
| 07/17/2013 | CN103203009A New application of partial metabolite of pentapeptide in preparation of myocardial ischemia resistant product |
| 07/17/2013 | CN103202996A Traditional Chinese medicine for treating myocarditis |
| 07/17/2013 | CN103202995A Traditional Chinese medicine for treating myocardial infarction |
| 07/17/2013 | CN103202992A Medicine for treating cardiac enlargement |
| 07/17/2013 | CN103202991A Drug for treatment of coronary heart disease and preparation method thereof |
| 07/17/2013 | CN103202964A Brain-improving and mind-calming medicinal liquor |
| 07/17/2013 | CN103202957A Traditional Chinese medicine composition for treating megrim |
| 07/17/2013 | CN103202956A Antihypertensive life-preserving health-care medicinal liquor |
| 07/17/2013 | CN103202953A Dendrobium nobile oral liquid with healthcare function for heart and cerebral vessels |
| 07/17/2013 | CN103202927A Traditional Chinese medicinal preparation used for treating hemorrhoids |
| 07/17/2013 | CN103202926A Soft capsule used for preventing and treating cardiovascular and cerebrovascular diseases and delaying senescence |
| 07/17/2013 | CN103202922A Externally applied traditional Chinese medicinal composition for treating hemorrhoids |
| 07/17/2013 | CN103202921A Blood pressure and blood fat reduction tea and preparation method thereof |
| 07/17/2013 | CN103202895A Spray for treating heart disease |
| 07/17/2013 | CN103202883A Component of capsule for treating angina caused by coronary heart disease and method for preparing component |
| 07/17/2013 | CN103202879A Traditional Chinese medicine composition for treating chronic cardiac failure and preparation method thereof |
| 07/17/2013 | CN103202877A Application of total salvianolic acids in drugs for preventing cardiotoxicity induced by arsenic trioxide and tumor inhibition synergic drugs |
| 07/17/2013 | CN103202871A Externally-applied medicine patch for dehydration and detumescence, and production method of same |